Abstract Introduction Obstructive sleep apnea (OSA) in children is a prevalent condition with long-term implications, well into adulthood. European Respiratory Society (ERS) has defined obstructive SDB as “a syndrome of upper airway dysfunction during sleep, characterized by snoring and/or increased respiratory effort secondary to increased upper airway resistance and pharyngeal collapsibility”. (1,2) Obstructive sleep apnoea (OSA) is a common paediatric health problem and children at risk need to be identified, investigated and treated in a timely manner because the resultant activation of inflammatory cascades can impose wide ranging effects, impacting on neurocognitive, cardiovascular and metabolic systems.(3) A well-established treatment protocol has not yet been prescribed has it is a multifactorial condition with multiple factors playing an important role in the severity of the condition. The emphasis of this article is to summarize the latest research and developments in paediatric OSA management techniques.